Leef Brands (LEEEF) Liabilities and Shareholders Equity (2024 - 2026)
Leef Brands (LEEEF) reported Liabilities and Shareholders Equity of $41.9 million for Q1 2026, up 14.96% sequentially from $36.4 million in Q4 2025.
Leef Brands (LEEEF) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $41.9 million in Q1 2026.
- For the quarter ending Q1 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $41.9 million; the trailing twelve-month figure through Mar 2026 stood at $121.2 million (changed N/A YoY), and the FY2025 full-year result was $36.4 million, down 15.3% from the prior year.
- Liabilities and Shareholders Equity climbed to $41.9 million in Q1 2026, from $36.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $43.0 million in Q4 2024 to a low of $36.4 million in Q4 2025.
- A 3-year average of $40.4 million and a median of $41.9 million in 2026 frame the typical range for Liabilities and Shareholders Equity.
- Peak annual rise in Liabilities and Shareholders Equity reached 15.3% in 2025, while the deepest fall reached 15.3% in 2025.
- Tracing LEEEF's Liabilities and Shareholders Equity over 3 years: stood at $43.0 million in 2024, then slipped by 15.3% to $36.4 million in 2025, then advanced by 14.96% to $41.9 million in 2026.
- Business Quant data shows LEEEF's Liabilities and Shareholders Equity at $41.9 million in Q1 2026, $36.4 million in Q4 2025, and $43.0 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | 43.40 Bn |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 40.04 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 15.15 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 98.91 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 6.71 Bn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | 25.35 Mn |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 36.83 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 4.91 Bn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 13.22 Bn |
| 10 | Leef Brands | 49.60 Mn | 43.84 Mn | 4.62 Mn | 41.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.85 Mn |
| Dec 31, 2025 | 36.40 Mn |
| Dec 31, 2024 | 42.98 Mn |